Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Guangdong Zhongsheng Pharmaceutical Co Ltd cash flow reinvestment rate. Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Cash Flow Reinvestment Rate of 0.93x as of September 2025, reinvesting CN¥82.19 Million (capex CN¥82.19 Million ) from operating cash flow of CN¥88.00 Million. Explore debt repayment capacity of Guangdong Zhongsheng Pharmaceutical Co L to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Cash flow reinvestment rate of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. Historical reinvestment intensity for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. Explore reinvestment intensity of Guangdong Zhongsheng Pharmaceutical Co L to see what proportion of operating cash flow is directed to capital expenditures.
Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2006–2024)
Guangdong Zhongsheng Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2006 to 2024. Year-by-year capital reinvestment analysis for Guangdong Zhongsheng Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Guangdong Zhongsheng Pharmaceutical Co L.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.49x | CN¥841.02 Million | CN¥337.84 Million | CN¥228.26 Million | ▼ -57.1% |
| 2023 | 5.80x | CN¥1.11 Billion | CN¥190.61 Million | CN¥363.06 Million | ▼ -33.1% |
| 2022 | 8.67x | CN¥547.02 Million | CN¥63.07 Million | CN¥267.96 Million | ▲ +681.6% |
| 2021 | 1.11x | CN¥691.07 Million | CN¥622.77 Million | CN¥213.76 Million | ▼ -47.2% |
| 2020 | 2.10x | CN¥291.87 Million | CN¥138.93 Million | CN¥154.43 Million | ▲ +100.4% |
| 2019 | 1.05x | CN¥263.23 Million | CN¥251.16 Million | CN¥128.33 Million | ▼ -3.4% |
| 2018 | 1.08x | CN¥354.39 Million | CN¥326.78 Million | CN¥143.48 Million | ▼ -29.3% |
| 2017 | 1.53x | CN¥567.68 Million | CN¥369.91 Million | CN¥124.28 Million | ▼ -38.1% |
| 2016 | 2.48x | CN¥838.45 Million | CN¥338.28 Million | CN¥141.19 Million | ▼ -12.1% |
| 2015 | 2.82x | CN¥542.27 Million | CN¥192.25 Million | CN¥76.57 Million | ▲ +42.2% |
| 2014 | 1.98x | CN¥199.54 Million | CN¥100.60 Million | CN¥199.54 Million | ▲ +96.7% |
| 2013 | 1.01x | CN¥111.91 Million | CN¥110.95 Million | CN¥111.91 Million | ▲ +85.5% |
| 2012 | 0.54x | CN¥77.42 Million | CN¥142.38 Million | CN¥77.42 Million | ▼ -79.3% |
| 2011 | 2.63x | CN¥185.41 Million | CN¥70.56 Million | CN¥185.41 Million | ▲ +259.6% |
| 2010 | 0.73x | CN¥67.02 Million | CN¥91.72 Million | CN¥67.02 Million | ▲ +222.9% |
| 2009 | 0.23x | CN¥22.83 Million | CN¥100.89 Million | CN¥22.83 Million | ▼ -15.4% |
| 2008 | 0.27x | CN¥19.49 Million | CN¥72.86 Million | CN¥19.49 Million | ▼ -48.6% |
| 2007 | 0.52x | CN¥25.67 Million | CN¥49.35 Million | CN¥25.67 Million | ▼ -5.4% |
| 2006 | 0.55x | CN¥9.84 Million | CN¥17.91 Million | CN¥9.84 Million | — |